To view a copy of this licence, visit About this article Cite this article Yi, S., Wen Xin, H., Fan, Q
Pharmacological treatment options for metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus: A systematic review
Several studies have been reported that claim the potential anti-inflammatory potential of LC or LC via the regulation of oxidative stress-induced inflammation
Treatment with PTL, SSZ or both agents in combination had no effect on the viability and confluency of MSC ( P 0.37) (Figure 5A) nor did siRNA treatment ( P 0.82) (Figure 5B and Online Supplementary Figure S8 )
Subscribing ensures you stay informed, connected, and equipped to accelerate your health, recovery, and performance through a comprehensive, medically informed approach